Open Label Assessment of Botulinum Toxin A for Pain Treatment in a Private Outpatient Setting

REFERENCES

• Argoff CE, Wheeler AH. Spinal and radicular pain syndromes. Neurologic Clinics., M-M Backonja. W.B. Saunders, Philadelphia 1998; 833–845
   Google Scholar
• Simons DG, Travell JG. Myofascial pain and dysfunction: The Trigger Point Manual. Vol 1. Upper half of body. Williams & Wilkins, Baltimore 1999; 11–93
   Google Scholar
• Hubbard DR, Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. Spine 1993; 18: 1803–1807
   PubMed Web of Science ®Google Scholar
• Simons DG. Clinical and etiological update of myofascial pain from trigger points. Clinical Overview and Pathogenesis of Fibromyalgia Syndrome, Myofascial Pain Syndrome, and Other Pain Syndromes., IJ Russell. The Haworth Medical Press, Binghamton, New York 1996; 93–122
   Google Scholar
• Jankovic T, Brin JF. Therapeutic uses of botulinum toxin. New Engl J Med. 1991; 342: 1186–1193
   Google Scholar
• Wheeler AH. The therapeutic uses of botulinum toxin. American Family Physician 1997; 55(Suppl 2)541–5
   PubMed Web of Science ®Google Scholar
• Coffield JA, Considine RV, Simpson LL. The site and mechanism of action of botulinum neurotoxin. Therapy with Botulinum Toxin., J Jankovic, M Hallett. Marcel Dekker, New York 1994; 3–13
   Google Scholar
• O'Brien CF. Clinical applications of botulinum toxin: Implications for pain management. Pain Digest 1998; 8: 342–345
   Google Scholar
• Wheeler AH, Goolkasian P, Gretz SS. A randomized, double-blind, prospective pilot study of botulinum toxin injections for refractory, unilateral, cervical-thoracic, paraspinal, myofascial pain syndrome. Spine 1998; 23: 1662–1667
   PubMed Web of Science ®Google Scholar
• Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998; 38: 468–471
   PubMed Web of Science ®Google Scholar
• Deyo RA. The nonoperative treatment of low back disorders: Differentiating useful from useless therapy, The Adult Spine: Principles and Practice., JW Frymoyer. Raven Press, New York 1991; 1567–1580
   Google Scholar
• Wheeler AH, Goolkasian P, Baird AC, Darden BV. Development of the neck pain and disability scale: Item analysis, face and criterion-related validity. Spine 1999; 24: 1290–1294
   PubMed Web of Science ®Google Scholar
• Zwart JA, Bovim G, Sand T, Sjaastad O. Tension headache: Botulinum toxin paralysis of temporal muscles. Headache 1994; 34: 458–462
   PubMed Web of Science ®Google Scholar
• Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997; 4(Suppl 2)S71–S73
   Google Scholar
• Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin [letter]. Anesthesiology 1994; 80(Suppl 3)705–706
   PubMed Web of Science ®Google Scholar
• Yue SK. Initial experience in the use of botulinum toxin A for the treatment of myofascial related muscle dysfunction. J Musculoske Pain 1995; 3(Suppl 1)22
   Google Scholar
• Cheshire WP, Abashjan SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994; 59: 65–69
   PubMed Web of Science ®Google Scholar
• Hobson D, Gladish D. Botulinum toxin injection for cervicogenic headache. Headache 1997; 36: 253–255
   Google Scholar
• Knusel B, DeGryse R, Grant M, Loesen JD, Ripp C, Stanton-Hicks M, Gibson J, Jenkins SW. Intramuscular injection of botulinum toxin type A [Botox] in chronic low back pain associated with muscle spasm [poster abstract]. American Pain Society. San Diego, CA November, 1998
   Google Scholar
• Klapper J, Mathew N, Saper T, Silberstein S, Chun E, Jenkins S. A multicenter, double-blind, placebo-controlled trial of two dosages of BOTOXR [botulinum toxin type A] in the prophylactic treatment of migraine [abstract]. American Association for the Study of Headache. Boston, MA June, 1999; 170
   Google Scholar
• Binder WJ, Brin M, Blitzer A, Schoenrock L. Botulinum toxin A [Botox] for the treatment of chronic daily headaches [abstract]. American Association for the Study of Headache. Boston, Ma June, 1999; 212
   Google Scholar
• Mauskop A. Botulinum toxin in the treatment of chronic daily headaches [abstract]. American Association for the Study of Headache. Boston, MA June, 1999; 205
   Google Scholar
• Relja MA, Korsic M. Treatment of tension-type headaches by injections of botulinum toxin type A: Double-blind placebo controlled study [abstract]. Neurology 1999; 52(Suppl 2)A203
   Google Scholar
• Guyer BM. Mechanisms for botulinum toxin in the relief of chronic pain. Current Review of Pain 1999; 3: 427–431
   PubMedGoogle Scholar
• Brin MF, Fahn S, Moskowitz CB, Blitzer A, Friedman A, Shale HM, Greene PE, List T, Lange D, Lovelace RE, McMahon D. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987; 2: 237–254
   PubMed Web of Science ®Google Scholar
• Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990; 40: 277–280
   PubMed Web of Science ®Google Scholar
• Greene P, Kang U, Fahn S, Brin M, Moskowitz CB, Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 1990; 40: 1213–1218
   PubMed Web of Science ®Google Scholar
• Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol (Stockh) 1993; 113: 400–404
   PubMed Web of Science ®Google Scholar
• Rosales RL, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injections. Muscle Nerve 1996; 19: 488–496
   PubMed Web of Science ®Google Scholar